US3120551A
(en)
|
1961-03-20 |
1964-02-04 |
Warner Lambert Pharmaceutical |
5-(4-biphenylyl)-3-methylvaleric acid and functional derivatives thereof
|
US3357887A
(en)
|
1962-12-03 |
1967-12-12 |
Upjohn Co |
4-phenoxy-3, 5-dihalophenylalkanols and hypocholesteremic compositions containing the same
|
US4069343A
(en)
|
1973-03-23 |
1978-01-17 |
American Home Products Corporation |
Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions
|
US4069347A
(en)
|
1976-08-02 |
1978-01-17 |
Emery Industries, Inc. |
Compositions of quaternary ammonium derivatives of lanolin acids
|
US4426453A
(en)
|
1980-09-18 |
1984-01-17 |
Amersham International Limited |
Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds
|
DE3037858A1
(de)
|
1980-10-07 |
1982-05-19 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
Verfahren zur herstellung von reaktiven, kupplungsfaehigen derivaten der schilddruesenhormone t (pfeil abwaerts)3(pfeil abwaerts) und t (pfeil abwaerts)4(pfeil abwaerts) und deren verwendung
|
DE3146897C2
(de)
|
1981-11-26 |
1984-04-19 |
Vdo Adolf Schindling Ag, 6000 Frankfurt |
Gehäuse für eine Uhr
|
US4554290A
(en)
|
1983-06-17 |
1985-11-19 |
Ciba-Geigy Corporation |
Oxamic acid derivatives
|
US4673691A
(en)
|
1984-11-05 |
1987-06-16 |
Nicholas Bachynsky |
Human weight loss inducing method
|
GB8501372D0
(en)
|
1985-01-18 |
1985-02-20 |
Smith Kline French Lab |
Chemical compounds
|
US5061798A
(en)
|
1985-01-18 |
1991-10-29 |
Smith Kline & French Laboratories, Ltd. |
Benzyl pyridyl and pyridazinyl compounds
|
US4968788A
(en)
|
1986-04-04 |
1990-11-06 |
Board Of Regents, The University Of Texas System |
Biologically reversible phosphate and phosphonate protective gruops
|
US5091552A
(en)
|
1986-06-30 |
1992-02-25 |
Board Of Regents, The University Of Texas System |
Novel antitumor aldophosphamide analogs
|
DE3718638A1
(de)
|
1987-06-04 |
1988-12-22 |
Thomae Gmbh Dr K |
Neue phenylethanolamine, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
US4929600A
(en)
|
1988-03-18 |
1990-05-29 |
University Of Deleware |
Endocrine manipulation to improve body composition of poultry
|
US5116828A
(en)
|
1989-10-26 |
1992-05-26 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Pharmaceutical composition for treatment of osteoporosis
|
IE903851A1
(en)
|
1989-11-03 |
1991-05-08 |
Boots Pharma Inc |
Iodothyronine polymers
|
EP0466909B1
(en)
|
1990-02-05 |
1995-06-28 |
British Technology Group (Usa) Incorporated |
Thyroid hormone for cardiac treatment
|
US5158978A
(en)
|
1990-02-05 |
1992-10-27 |
British Technology Group (U.S.A.) |
Thyroid hormone treatment of acute cardiovascular compromise
|
ES2118069T3
(es)
|
1990-09-14 |
1998-09-16 |
Acad Of Science Czech Republic |
Profarmacos de fosfonatos.
|
ATE164063T1
(de)
|
1991-12-30 |
1998-04-15 |
Akzo Nobel Nv |
Thyroaktive zusammensetzung mit kontrollierter freigabe
|
US5284971A
(en)
|
1992-07-16 |
1994-02-08 |
Syntex (U.S.A.) Inc. |
4-(3-cyclohexyl-4-hydroxy or-methoxy phenylsulfonyl) 3,5 dibromo phenyl acetic thyromimetic cholesterol-lowering agents
|
ES2108855T3
(es)
|
1992-07-21 |
1998-01-01 |
Ciba Geigy Ag |
Derivados de acido oxamico como agentes hipocolesteremicos.
|
US5741803A
(en)
|
1992-09-05 |
1998-04-21 |
Smithkline Beecham Plc |
Substituted thiazolidinedionle derivatives
|
ES2102210T3
(es)
|
1992-09-09 |
1997-07-16 |
Fisons Plc |
Envase para medicamentos.
|
US5571840A
(en)
|
1993-06-22 |
1996-11-05 |
The Regents Of The University Of Michigan |
Method for treating central nervous system ischemia
|
US5519163A
(en)
|
1993-10-15 |
1996-05-21 |
Merck & Co., Inc. |
Inhibitors of phosphoinositide-specific phospholipase C
|
GB9401892D0
(en)
|
1994-02-01 |
1994-03-30 |
Boots Co Plc |
Therapeutic agents
|
AU1942995A
(en)
|
1994-03-15 |
1995-10-03 |
K.U. Leuven Research & Development |
New use of growth hormone
|
GB9416219D0
(en)
|
1994-08-11 |
1994-10-05 |
Karobio Ab |
Receptor ligands
|
DE19502209A1
(de)
|
1995-01-25 |
1996-08-01 |
Hoechst Ag |
Phosphonoessigsäure-Derivate und deren Verwendung zur Behandlung von degenerativen Gelenkserkrankungen
|
US6221911B1
(en)
|
1995-06-07 |
2001-04-24 |
Karo Bio Ab |
Uses for thyroid hormone compounds or thyroid hormone-like compounds
|
WO1996040048A2
(en)
|
1995-06-07 |
1996-12-19 |
Karo Bio Ab |
Novel uses for thyroid hormones or thyroid hormone-like compounds
|
US6380255B1
(en)
|
1995-06-07 |
2002-04-30 |
Karo Bio Ab |
Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
|
DE69636677D1
(de)
|
1995-12-13 |
2006-12-14 |
Univ California |
Kristalle der mit einem Ligand komplexierten Ligandenbindedomäne des Schilddrüsenhormonrezeptors
|
US6266622B1
(en)
|
1995-12-13 |
2001-07-24 |
Regents Of The University Of California |
Nuclear receptor ligands and ligand binding domains
|
US6361992B1
(en)
|
1996-05-08 |
2002-03-26 |
The United States Of America As Represented By The Department Of Health And Human Services |
Thyroid stimulating hormone superagonists
|
US6576636B2
(en)
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
ES2175415T3
(es)
|
1996-07-18 |
2002-11-16 |
Pfizer |
Inhibidores de metaloproteasas matriciales basados en fosfinato.
|
JP3345428B2
(ja)
|
1996-08-20 |
2002-11-18 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
合成甲状腺ホルマン組成物を使用した眼の処置
|
ES2264171T3
(es)
|
1996-10-24 |
2006-12-16 |
Novartis Ag |
Acidos aminoalcanofosfonicos sustituidos.
|
AU2089297A
(en)
|
1997-03-17 |
1998-10-12 |
Yun K. Tam |
Composition for prevention of hepatic steatosis
|
US5951989A
(en)
|
1997-04-07 |
1999-09-14 |
Heymann; Warren R. |
Method for the treatment of dry skin
|
US5883294A
(en)
|
1997-06-18 |
1999-03-16 |
The Regeants Of The University Of California |
Selective thyroid hormone analogs
|
GB9713739D0
(en)
|
1997-06-27 |
1997-09-03 |
Karobio Ab |
Thyroid receptor ligands
|
US5922775A
(en)
|
1997-10-23 |
1999-07-13 |
Octamer, Inc. |
Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity
|
KR20010033028A
(ko)
|
1997-12-11 |
2001-04-25 |
더 챈슬러 마스터즈 앤드 스칼라스 오브 더 유니버시티 오브 옥스포드 |
막-관련 바이러스 복제의 억제
|
AU2586999A
(en)
|
1998-02-03 |
1999-08-16 |
University Of Arkansas, The |
Method for the stimulation of sperm production and gonadal development in animals
|
WO1999045016A2
(en)
|
1998-03-06 |
1999-09-10 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
AU4154799A
(en)
|
1998-06-02 |
1999-12-20 |
Arthromics Plc |
Compounds which interact with the thyroid hormone receptor for the treatment of fibrotic disease
|
EP1089968B1
(en)
|
1998-06-30 |
2005-04-20 |
The Regents Of The University Of California |
Thyroid hormone analogues and methods for their preparation
|
GB9816935D0
(en)
|
1998-08-05 |
1998-09-30 |
Karobio Ab |
Novel glucocortoid and thyroid receptor ligands for the treatment of metabolic disorders
|
EP0994570A1
(en)
|
1998-10-12 |
2000-04-19 |
Sony International (Europe) GmbH |
Spread spectrum channel estimator with inter-path interference cancellation
|
GB9828442D0
(en)
|
1998-12-24 |
1999-02-17 |
Karobio Ab |
Novel thyroid receptor ligands and method II
|
US6495533B1
(en)
|
1999-02-23 |
2002-12-17 |
Ono Pharmaceutical Co., Ltd. |
Drugs containing phosphoric acid derivatives as the active ingredient
|
US6344481B1
(en)
|
1999-03-01 |
2002-02-05 |
Pfizer Inc. |
Thyromimetic antiobesity agents
|
CA2363145C
(en)
|
1999-03-01 |
2006-02-14 |
Pfizer Products Inc. |
Oxamic acids and derivatives as thyroid receptor ligands
|
DE60018225T2
(de)
|
1999-03-01 |
2005-12-29 |
Pfizer Products Inc., Groton |
Oxamsäuren mit einer Cyanogruppe als Liganden für den Thyroidrezeptor
|
WO2000052015A2
(en)
|
1999-03-05 |
2000-09-08 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing prodrugs
|
CO5160290A1
(es)
|
1999-03-29 |
2002-05-30 |
Novartis Ag |
Derivados de acido fenoxifeniloxamico sustituido .
|
US6790978B2
(en)
|
1999-03-29 |
2004-09-14 |
Novartis Ag |
Thyromimetic organic compounds
|
US6599942B1
(en)
|
1999-03-29 |
2003-07-29 |
Novartis Ag |
Thyromimetic organic compounds
|
US6776984B1
(en)
|
1999-08-20 |
2004-08-17 |
George R. Schwartz |
Induced regeneration and repair of damaged neurons and nerve axon myelin
|
ES2226839T3
(es)
|
1999-05-05 |
2005-04-01 |
MERCK & CO., INC. |
Nuevos catecoles como agentes antimicrobianos.
|
US6468755B1
(en)
|
1999-08-10 |
2002-10-22 |
Joslin Diabetes Center, Inc. |
Method for identifying compounds for treatment of insulin resistance
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
AU7361400A
(en)
|
1999-09-08 |
2001-04-10 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
US6414002B1
(en)
|
1999-09-22 |
2002-07-02 |
Bristol-Myers Squibb Company |
Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
|
US6787652B1
(en)
|
1999-09-30 |
2004-09-07 |
Pfizer, Inc. |
6-Azauracil derivatives as thyroid receptor ligands
|
US6627660B1
(en)
|
1999-11-16 |
2003-09-30 |
New River Pharmaceuticals Inc. |
Stabilized thyroxine compounds
|
GB9927056D0
(en)
|
1999-11-17 |
2000-01-12 |
Karobio Ab |
Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
|
EP1127882A1
(en)
|
2000-01-25 |
2001-08-29 |
Pfizer Products Inc. |
Tetrazole compounds as thyroid receptor ligands
|
CZ20022771A3
(cs)
|
2000-02-17 |
2003-09-17 |
Bristol-Myers Squibb Company |
Ligandy thyreoidního receptoru odvozené od anilinu
|
US6852706B1
(en)
|
2000-03-22 |
2005-02-08 |
The Wistar Institute |
Methods and compositions for healing heart wounds
|
US6664291B2
(en)
|
2000-03-31 |
2003-12-16 |
Pfizer, Inc. |
Malonamic acids and derivatives thereof as thyroid receptor ligands
|
EP1268404B1
(en)
|
2000-03-31 |
2008-01-02 |
Pfizer Products Inc. |
Malonamic acids and derivatives thereof as thyroid receptor ligands
|
US20030181407A1
(en)
|
2000-04-17 |
2003-09-25 |
Marie-France Palin |
Steatosis-modulating factors and uses thereof
|
US6620830B2
(en)
|
2000-04-21 |
2003-09-16 |
Pfizer, Inc. |
Thyroid receptor ligands
|
US6395784B1
(en)
|
2000-06-07 |
2002-05-28 |
Bristol-Myers Squibb Company |
Benzamide ligands for the thyroid receptor
|
GB0015205D0
(en)
|
2000-06-21 |
2000-08-09 |
Karobio Ab |
Bioisosteric thyroid receptor ligands and method
|
US20020077364A1
(en)
|
2000-07-06 |
2002-06-20 |
Ramaswamy Murari |
Thyroid hormone formulations
|
WO2002004515A1
(en)
|
2000-07-10 |
2002-01-17 |
Btg International Limited |
Insulin derivatives and synthesis thereof
|
WO2002009757A1
(fr)
|
2000-08-01 |
2002-02-07 |
Shionogi & Co., Ltd. |
Agents de prevention ou remedes contre l'obesite ou la steatose hepatique
|
IL137672A0
(en)
|
2000-08-03 |
2001-10-31 |
Dpharm Ltd |
Derivatives of branched-chain lipophilic molecules and uses thereof
|
DE10038007A1
(de)
|
2000-08-04 |
2002-02-14 |
Bayer Ag |
Neue Amino-und Amido-Diphenylether für Arzneimittel
|
WO2002015845A2
(en)
|
2000-08-21 |
2002-02-28 |
Merck & Co., Inc. |
Anti-hypercholesterolemic drug combination
|
DE10046029A1
(de)
|
2000-09-18 |
2002-03-28 |
Bayer Ag |
Indazole
|
JP2004513891A
(ja)
|
2000-09-27 |
2004-05-13 |
アイレックス オンコロジー リサーチ エス.エイ. |
α−置換β−アミノエチルホスホネート
|
AU2002223626A1
(en)
|
2000-10-20 |
2002-04-29 |
Novartis Ag |
Combinations of a thyromimetic compound and a statin
|
JP2004517851A
(ja)
|
2000-12-27 |
2004-06-17 |
バイエル アクチェンゲゼルシャフト |
甲状腺受容体のリガンドとしてのインドール誘導体
|
EP1362846A4
(en)
|
2001-01-26 |
2006-10-04 |
Takeda Pharmaceutical |
AMINOETHANOLDERIVATE
|
AU2002228317A1
(en)
|
2001-01-29 |
2002-08-12 |
Insight Strategy And Marketing Ltd |
Benz-1,3-azole derivatives and their uses as heparanase inhibitors
|
US6716877B2
(en)
|
2001-01-31 |
2004-04-06 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels
|
US6534676B2
(en)
|
2001-01-31 |
2003-03-18 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Method to treat chronic heart failure and/or elevated cholesterol levels using 3,5-diiodothyropropionic acid and method to prepare same
|
CA2435820A1
(en)
|
2001-02-08 |
2002-08-15 |
Karo Bio Ab |
Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands
|
WO2002066017A1
(en)
|
2001-02-20 |
2002-08-29 |
Abbott Laboratories |
Liothyronine sodium and levothyroxine sodium combination
|
AU2002255732B2
(en)
|
2001-03-14 |
2006-03-09 |
Eli Lilly And Company |
Fluorinated trienes and their use as RXR modulators
|
DE10115408A1
(de)
|
2001-03-29 |
2002-10-02 |
Bayer Ag |
Benzofuran-Derivate
|
US6825201B2
(en)
|
2001-04-25 |
2004-11-30 |
Bristol-Myers Squibb Company |
Indole, azaindole and related heterocyclic amidopiperazine derivatives
|
GB0111861D0
(en)
|
2001-05-15 |
2001-07-04 |
Karobio Ab |
Novel compounds
|
FR2825926A1
(fr)
|
2001-06-14 |
2002-12-20 |
Sod Conseils Rech Applic |
Derives d'imidazoles modulant les canaux sodiques
|
WO2003003013A1
(en)
|
2001-06-29 |
2003-01-09 |
University Of Massachusetts |
Non-nuclear effects of thyroid hormone
|
ATE381542T1
(de)
|
2001-08-13 |
2008-01-15 |
Phenex Pharmaceuticals Ag |
Nr1h4-kern-rezeptor-bindende verbindungen
|
WO2003061557A2
(en)
|
2001-08-14 |
2003-07-31 |
King Pharmaceuticals, Inc. |
Levothyroxine pharmaceutical compositions, methods of making and methods of administration
|
WO2003018515A2
(en)
|
2001-08-24 |
2003-03-06 |
Karo Bio Ab |
Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
|
ATE313325T1
(de)
|
2001-09-26 |
2006-01-15 |
Pfizer Prod Inc |
Indolcaroboxylsäure als thyroidrezeptor-liganden
|
US6806381B2
(en)
|
2001-11-02 |
2004-10-19 |
Bristol-Myers Squibb Company |
Process for the preparation of aniline-derived thyroid receptor ligands
|
EP1442028A4
(en)
|
2001-11-06 |
2009-11-04 |
Bristol Myers Squibb Co |
SUBSTITUTED ACID DERIVATIVES, WHICH APPRECIATE AS ANTIDIBILICS AND AGENTS AGAINST OBESITAS, AND METHODS
|
US6831102B2
(en)
|
2001-12-07 |
2004-12-14 |
Bristol-Myers Squibb Company |
Phenyl naphthol ligands for thyroid hormone receptor
|
AU2003216054B2
(en)
|
2002-01-18 |
2007-01-04 |
Merck & Co., Inc. |
Selective S1P1/Edg1 receptor agonists
|
US7230031B2
(en)
|
2002-01-30 |
2007-06-12 |
Kissei Pharmaceutical Co., Ltd. |
Thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
|
AU2003211022A1
(en)
|
2002-02-19 |
2003-09-09 |
Ilex Products, Inc. |
Aminodiphosphonate apolipoprotein e modulators
|
JP2006500909A
(ja)
|
2002-03-04 |
2006-01-12 |
スミスクライン ビーチャム コーポレーション |
甲状腺ホルモン代謝ならびにコレステロールおよび脂質代謝を核内受容体carを介して調節するための組成物および方法
|
ATE377644T1
(de)
|
2002-03-25 |
2007-11-15 |
Applera Corp |
Systeme und verfahren zum nachweis der funktion nukleärer rezeptoren unter verwendung von reporterenzymmutanten komplementierungen
|
GB0208384D0
(en)
|
2002-04-11 |
2002-05-22 |
Karobio Ab |
Novel compounds
|
AU2003225305A1
(en)
|
2002-05-08 |
2003-11-11 |
Bristol-Myers Squibb Company |
Pyridine-based thyroid receptor ligands
|
EP1364962A1
(en)
|
2002-05-24 |
2003-11-26 |
Stichting tot bevordering van de wetenschap der Endocrinologie |
Use of monocarboxylate transporter proteins for thyroid hormone transport
|
WO2003105760A2
(en)
|
2002-06-15 |
2003-12-24 |
Enteromed, Inc. |
Prevention and treatment of nonalcoholic fatty liver disease (nafld) by antagonism of the receptor to glucose-dependent insulinotropic polypeptide (gip)
|
US20040137441A1
(en)
|
2003-01-15 |
2004-07-15 |
Isis Pharmaceuticals Inc. |
Modulation of thyroid hormone receptor interactor 3 expression
|
JP5685355B2
(ja)
|
2002-07-04 |
2015-03-18 |
ジーランド ファーマ アクティーゼルスカブ |
Glp−1および糖尿病の処置方法
|
KR101120337B1
(ko)
|
2002-07-09 |
2012-02-29 |
브리스톨-마이어스 스큅 컴퍼니 |
항당뇨제 및 항비만제로서 유용한 치환된 헤테로시클릭유도체 및 방법
|
GB0215978D0
(en)
|
2002-07-10 |
2002-08-21 |
Karobio Ab |
Novel compounds
|
WO2004014318A2
(en)
|
2002-08-10 |
2004-02-19 |
King Pharmaceuticals, Inc. |
Levothyroxine compositions and methods
|
GB0219022D0
(en)
|
2002-08-15 |
2002-09-25 |
Karobio Ab |
Novel thyromimetic compounds
|
AU2003270615A1
(en)
|
2002-09-19 |
2004-04-08 |
First Circle Medical, Inc. |
Treatment of steatosis using hyperthermia
|
US20040152783A1
(en)
|
2002-11-05 |
2004-08-05 |
Olon Lawrence Peter |
Controlled absorption of admixed thyroid hormone formulations
|
ITMI20022777A1
(it)
|
2002-12-27 |
2004-06-28 |
Altergon Sa |
Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
|
US20040142868A1
(en)
|
2003-01-21 |
2004-07-22 |
Sleeman Mark W. |
Method of treating liver steatosis in a mammal
|
JP2006516620A
(ja)
|
2003-01-24 |
2006-07-06 |
ブリストル−マイヤーズ スクイブ カンパニー |
甲状腺受容体におけるシクロアルキル含有アニリドリガンド
|
TW200504021A
(en)
|
2003-01-24 |
2005-02-01 |
Bristol Myers Squibb Co |
Substituted anilide ligands for the thyroid receptor
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
US20040176294A1
(en)
|
2003-03-05 |
2004-09-09 |
Kelly James D. |
Use of thyroid-stimulating hormone to induce lipolysis
|
AU2003901813A0
(en)
|
2003-04-15 |
2003-05-01 |
Vital Health Sciences Pty Ltd |
Pharmaceutical derivatives
|
US7557143B2
(en)
|
2003-04-18 |
2009-07-07 |
Bristol-Myers Squibb Company |
Thyroid receptor ligands
|
WO2004103289A2
(en)
|
2003-05-14 |
2004-12-02 |
New York University |
Driverse thyroid hormone receptor antagonists and uses thereof
|
ITRM20030363A1
(it)
|
2003-07-24 |
2005-01-25 |
Fernando Goglia |
Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico di esse.
|
WO2005016862A1
(en)
|
2003-08-14 |
2005-02-24 |
Asahi Kasei Pharma Corporation |
Substituted arylalkanoic acid derivative and use thereof
|
US6952844B2
(en)
|
2003-08-27 |
2005-10-11 |
Danaher Thomas C |
Bed-tent
|
WO2005028488A1
(en)
|
2003-09-12 |
2005-03-31 |
Quatrx Pharmaceuticals Co. |
Heteroaryl phosphinyl and thiophosphinyl compounds for regulation of glucose, triglycerides, and ldl/hdl levels
|
EP1666035A4
(en)
|
2003-09-26 |
2010-04-28 |
Chugai Pharmaceutical Co Ltd |
MEDICINAL COMPOSITION FOR THE TREATMENT OF HEPATIC STEATOSIS OR LIVER DISEASES
|
US7157434B2
(en)
|
2003-10-27 |
2007-01-02 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
CN1882327A
(zh)
*
|
2003-11-19 |
2006-12-20 |
症变治疗公司 |
含磷的新的拟甲状腺素药
|
WO2006128055A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
KR20070029196A
(ko)
*
|
2004-06-08 |
2007-03-13 |
메타베이시스 테라퓨틱스, 인크. |
고리 에스테르의 루이스 산 매개 합성
|
CA2606499C
(en)
|
2005-05-26 |
2017-06-13 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the treatment of fatty liver diseases
|
US20080261913A1
(en)
|
2006-12-28 |
2008-10-23 |
Idenix Pharmaceuticals, Inc. |
Compounds and pharmaceutical compositions for the treatment of liver disorders
|
EP2299976A4
(en)
|
2008-12-22 |
2014-07-23 |
Otonomy Inc |
SELF-CONTROLLED RELEASE SENSORY CELL MODULATOR COMPOSITIONS AND METHODS FOR TREATING OTIC DISORDERS
|
KR101785120B1
(ko)
|
2009-04-27 |
2017-10-12 |
이뮤론 리미티드 |
병적 장애의 치료 및/또는 예방에 이용되는 항-lps 풍부한 면역글로블린 조제물
|
US20150045389A1
(en)
|
2012-04-10 |
2015-02-12 |
Trustees Of Dartmouth College |
Compounds and methods for inhibiting cif virulence factor
|
AU2013255103B2
(en)
|
2012-05-02 |
2016-09-29 |
Pharmaxis Ltd. |
Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
|
US9587403B2
(en)
|
2014-04-29 |
2017-03-07 |
Platinum Roofing, Inc. |
Fixture support for membrane roof
|
US9913819B2
(en)
|
2014-06-12 |
2018-03-13 |
Yale University |
Methods of treating or preventing fibrotic lung diseases
|
MX2018003179A
(es)
|
2015-09-16 |
2018-08-21 |
Tobira Therapeutics Inc |
Terapia de combinación con cenicriviroc para el tratamiento de fibrosis.
|
JP6957601B2
(ja)
|
2016-04-22 |
2021-11-02 |
メタベイシス・セラピューティクス・インコーポレイテッド |
甲状腺ホルモン受容体アゴニスト及びその使用
|
US11351183B2
(en)
*
|
2016-04-22 |
2022-06-07 |
Viking Therapeutics, Inc. |
Use of thyroid beta-agonists
|
KR20240074912A
(ko)
|
2016-09-16 |
2024-05-28 |
바이킹 테라퓨틱스 인코포레이티드 |
갑상선-관련 부작용을 감소시키는 방법
|
CA3044059A1
(en)
|
2016-11-21 |
2018-05-24 |
Viking Therapeutics, Inc. |
Method of treating glycogen storage disease
|
BR112019011740A2
(pt)
|
2016-12-09 |
2019-10-29 |
Cadila Healthcare Ltd |
composição farmacêutica e método para o tratamento de colangite biliar primária
|
BR112019025659A2
(pt)
|
2017-06-05 |
2020-08-25 |
Viking Therapeutics, Inc. |
composições para o tratamento de fibrose
|
CN107469086A
(zh)
|
2017-07-31 |
2017-12-15 |
深圳市润佳通科技有限公司 |
甲状腺素受体类似物及其盐或前药在制备治疗和/或预防肺部疾病的药物中的应用
|
EP3890747A4
(en)
|
2018-12-05 |
2022-08-03 |
Viking Therapeutics, Inc. |
COMPOSITIONS FOR THE TREATMENT OF FIBROSIS AND INFLAMMATION
|
EP3890748A4
(en)
|
2018-12-05 |
2022-12-21 |
Viking Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES
|